InvestorsHub Logo
Followers 52
Posts 4107
Boards Moderated 0
Alias Born 07/03/2005

Re: buddwhyzer post# 2546

Friday, 05/12/2017 1:18:25 PM

Friday, May 12, 2017 1:18:25 PM

Post# of 4273
Money flow has turned positive in Synergy Pharmaceuticals (SGYP +10.8%) albeit on modestly higher volume. Earlier today, would-be competitor Ardelyx (ARDX -36.7%) announced positive late-stage data on IBS-C candidate tenapanor but with a 14.6% rate of diarrhea, higher that Trulance's 5% (data from studies in chronic ideopathic constipation).

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.